CJC-1295 vs GHRP-2
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
PubMed paper counts, ClinicalTrials.gov listings, and regulatory context—aggregated from public databases.
GH release
A long-acting GHRH analog that extends GH pulses—often stacked with ipamorelin.
CJC-1295 mimics growth hormone-releasing hormone. The DAC version binds albumin for a longer half-life. Intended effects: lean mass support, sleep quality, and recovery. Prescription analogs exist in different forms; gra…
GH release
A growth-hormone secretagogue peptide from the GHRP family—stronger GH pulse than ipamorelin, with more appetite stimulation.
GHRP-2 binds ghrelin receptors to trigger GH release from the pituitary. It is more potent than ipamorelin for GH output but often causes noticeable hunger. Like other GHRPs it is not FDA-approved for athletic or anti-ag…
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context. CJC-1295 is categorized as GH release; GHRP-2 as GH release. CJC-1295: A long-acting GHRH analog that extends GH pulses—often stacked with ipamorelin. GHRP-2: A growth-hormone secretagogue peptide from the GHRP family—stronger GH pulse than ipamorelin, with more appetite stimulation.
No. They are different molecules with distinct names on labels and in research databases. Always match the full INCI or drug name—not a nickname on the front of the package.
Neither page is medical or anti-doping advice. Research peptides discussed in fitness communities may be prohibited in tested sport or unavailable as OTC supplements. Verify WADA lists and talk to a clinician.